WHEN NANO COMES TO LIFE
WHEN NANO COMES TO LIFE
WHEN NANO COMES TO LIFE

WE RETHINK THERAPY

With tailor-made nanocarriers, we will set new standards for the targeted, efficient and low-risk use of active pharmaceutical ingredients and other highly potent substances for medical and life science applications.

OUR VISION

We save human lives

by targeted use of highly potent substances

We rethink therapy

via tailor-made nanocarriers for efficiency and safety

We treat the untreatable

e.g. septic liver failure

NEWS

11th September 2023

SEPSIS UPDATE 2023: SMARTDYELIVERY BRINGS ITSELF UP TO DATE ON THE LATEST SEPSIS RESEARCH

From 6-8 September 2023 SmartDyeLivery took part in the 11th international congress on sepsis research in Weimar. With the motto „Immunotherapies – Advances and Adaptions“ the German Sepsis Society discussed the current situation of the critical care community...

5th September 2023

SMARTDYELIVERY CONVINCES EXISTING INVESTORS TO INCREASE THEIR PARTICIPATION

In the latest round of financing, both the Foundation for Technology, Innovation and Research Thuringia (STIFT) and an existing private investor increased their holdings. The investors were motivated by the company's latest milestone - the approval of the BfArM to conduct a first clinical trial on healthy subjects. STIFT aims to promote regional science and has been supporting the innovative therapeutic concept of SmartDyeLivery since 2018.

19th July 2023

SMARTDYELIVERY GAINS SME STATUS FROM THE EUROPEAN MEDICINES AGENCY (EMA)

Our application for the registration as an SME (small and medium-sized enterprise) has been successful. Being in the SME register of the EMA entails a full or partial exemption from fees, e.g., for scientific advice or further training.

64

Patents Granted

EP, US, JP, CN, CA …

105

Pending Applications

EP, US, JP, CN, CA …

1

Utility Model

∞

Countless Company Secrets